Clinical Mass Spectrometry Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-19　·　153 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 4.44 Bn
2033 年預估規模: USD 6.76 Bn
年複合成長率 CAGR: 6.14%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Clinical Mass Spectrometry Market, By Product Type (Gas chromatographymass spectrometry (GC-MS) instrument , Liquid chromatographymass spectrometry (LC- MS) instrument, MALDI-TOF mass spectrometer, Capillary electrophoresismass spectrometry, and Ion mobility spectrometry-mass spectrometry), By Application (Clinical Testing, Proteomics, and Drug discovery), By End User (Research Laboratories, Diagnostic Laboratories, and Hospitals), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Clinical mass spectrometry plays a vital role in the drug discovery pipeline for development of personalized medicines. It is further used in live imaging of biological tissue samples for detection of biomarkers. Cost reduction and improved assay quality are the key factors driving the adoption of mass spectrometry technique. According to the American Association for Clinical Chemistry (AACC), the greater specificity of liquid chromatography–mass spectrometry (LC-MS) enables the measuring of testosterone in the patients with low endogenous concentrations. This technique is more reliable than traditional immunoassays, especially in women and children. This has led to an early adoption of the most recent generation of instruments using an established technology in the laboratories. Clinical diagnostic mass spectrometers have the potential to analyze limited range of samples such as biomarkers, proteins or drug molecules at once, and in Some cases with low concentrations. Thus, these devices are a valuable tool in diagnostics and laboratory settings. Furthermore, it allows researchers to determine pharmacokinetic profiles of drugs that are administered in micro doses. The technology shift from traditional systems to high-resolution technologies such as Quadrupole-time of flight (Q-TOF) mass spectrometry and the demand for this spectrometry technique type is expected to grow rapidly owing to advantages such as accuracy, improved resolution, and sensitivity for clinical diagnostic applications. Market Dynamics Technological advancements and product launches by key players are expected to drive growth of the clinical mass spectrometry market. Advancements in technology include miniaturization of mass spectrometry instruments and increasing automation within spectrometric units to reduce human efforts and improve efficiency of the instrument. For instance, a fully automated analyzer launched by Thermo Fisher, in June 2017 that can be customized for compatibility with laboratory information systems. Key features of the study • This report provides in-depth analysis of the global clinical mass spectrometry market size (US$ Mn), and compound annual growth rate (CAGR (%)) over the forecast period: 2026 – 2033, considering 2025 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global clinical mass spectrometry market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies • Key players covered as a part of this study include Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, market expansion, and marketing tactics • The global clinical mass spectrometry report caters to various stakeholders in this industry which include investors, product manufacturers, distributors, and suppliers of clinical mass spectrometry, research and consulting firms, new entrants, and financial analysts. Market Segmentation • By Product Type o Gas chromatography-mass spectrometry (GC-MS) instrument o Liquid chromatography–mass spectrometry (LC-MS) instrument o Maldi TOF mass spectrometer o Capillary electrophoresis–mass spectrometry o Ion mobility spectrometry-mass spectrometry • By Application o Clinical Testing o Proteomics o Drug Discovery • By End User o Hospitals o Research Laboratories o Diagnostic Laboratories • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Clinical Mass Spectrometry Market - Competitive Landscape o Bruker Corporation o Kore Technology Limited o Bergman Messgerate Entwicklung KG o Mass Spectrometry Instruments (MSI) o Thermo Fisher Scientific Inc. o Agilent Technologies o Danaher Corporations

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Product Type  Market Snippet, By Application  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Regulatory Landscape o Porter’s Five Forces Model 4. Global Clinical Mass Spectrometry Market, By Product Type, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2017 – 2033  Segment Trends o Gas chromatography-mass spectrometry (GC-MS) instrument  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Liquid chromatography–mass spectrometry (LC-MS) instrument  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Maldi TOF mass spectrometer  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Capillary electrophoresis–mass spectrometry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Ion mobility spectrometry-mass spectrometry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) 5. Global Clinical Mass Spectrometry Market, By Application, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2017 – 2033  Segment Trends o Clinical Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Proteomics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Drug Discovery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) 6. Global Clinical Mass Spectrometry Market, By End User, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2017 – 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Research Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn) 7. Global Clinical Mass Spectrometry Market, By Region, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, By Region, 2018– 2033  Regional Trends o North America  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o U.S. o Canada o Europe  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o China o Japan o India o ASEAN o Australia o South Korea o Rest of Asia Pacific o Latin America  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Africa  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o North Africa o Central Africa o South Africa o Middle East  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Application, 2026 – 2033, (USD Bn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Bn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Bn) o GCC Countries o Israel o Rest of Middle East 8. Competitive Landscape o Company Profiles  Bruker Corporations o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Kore Technologies o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Bergman Messgerate Entwicklung KG o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Mass Spectrometry Instruments (MSI) o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  RGB Photonics o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  ABLE Biosciences o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Thermo Fisher Scientific Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Danaher Corporations o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Agilent Technologies o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Shimadzu Corporation o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  PerkinElmer Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies o Analyst Views 9. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Bruker CorporationKore Technology LimitedBergman Messgerate Entwicklung KGMass Spectrometry Instruments (MSI)Thermo Fisher Scientific Inc.Agilent TechnologiesDanaher Corporations

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們